Fourth BNT162b2 vaccine dose provides short-term effectiveness against Covid-19 related outcomes
1. Patients receiving the fourth dose of BNT162b2 (Pfizer-BioNTech) showed reduced rates of symptomatic Covid-19 infection and hospitalization compared to ...